Pegg AE - Search Results

1

Polyamines as targets for therapeutic intervention.

Marton LJ, Pegg AE. Marton LJ, et al. Among authors: pegg ae. Annu Rev Pharmacol Toxicol. 1995;35:55-91. doi: 10.1146/annurev.pa.35.040195.000415. Annu Rev Pharmacol Toxicol. 1995. PMID: 7598507 Review.

2

The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells.

Sarkar A, Dolan ME, Gonzalez GG, Marton LJ, Pegg AE, Deen DF. Sarkar A, et al. Among authors: pegg ae. Cancer Chemother Pharmacol. 1993;32(6):477-81. doi: 10.1007/BF00685893. Cancer Chemother Pharmacol. 1993. PMID: 8258197

3

Possible factors in the potentiation of 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl-1-nitrosourea cytotoxicity by alpha-difluoromethylornithine in 9L rat brain tumor cells.

Oredsson SM, Pegg AE, Alhonen-Hongisto L, Deen DF, Marton LJ. Oredsson SM, et al. Among authors: pegg ae. Eur J Cancer Clin Oncol. 1984 Apr;20(4):535-42. doi: 10.1016/0277-5379(84)90240-2. Eur J Cancer Clin Oncol. 1984. PMID: 6426969

4

Potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in 9L rat brain tumor cells by methylglyoxal-bis(guanylhydrazone), an inhibitor of S-adenosyl-L-methionine decarboxylase.

Hung DT, Oredsson SM, Pegg AE, Deen DF, Marton LJ. Hung DT, et al. Among authors: pegg ae. Eur J Cancer Clin Oncol. 1984 Mar;20(3):417-20. doi: 10.1016/0277-5379(84)90090-7. Eur J Cancer Clin Oncol. 1984. PMID: 6538500

5

Directions for polyamine research.

Marton LJ, Pegg AE, Morris DR. Marton LJ, et al. Among authors: pegg ae. J Cell Biochem. 1991 Jan;45(1):7-8. doi: 10.1002/jcb.240450105. J Cell Biochem. 1991. PMID: 2005186 Review. No abstract available.

6

Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.

Deen DF, Chiarodo A, Grimm EA, Fike JR, Israel MA, Kun LE, Levin VA, Marton LJ, Packer RJ, Pegg AE, et al. Deen DF, et al. Among authors: pegg ae. J Neurooncol. 1993 Jun;16(3):243-72. doi: 10.1007/BF01057041. J Neurooncol. 1993. PMID: 7905510 No abstract available.

7

Ornithine decarboxylase as an enzyme target for therapy.

McCann PP, Pegg AE. McCann PP, et al. Among authors: pegg ae. Pharmacol Ther. 1992;54(2):195-215. doi: 10.1016/0163-7258(92)90032-u. Pharmacol Ther. 1992. PMID: 1438532 Review.

8

Toxicity of polyamines and their metabolic products.

Pegg AE. Pegg AE. Chem Res Toxicol. 2013 Dec 16;26(12):1782-800. doi: 10.1021/tx400316s. Epub 2013 Nov 25. Chem Res Toxicol. 2013. PMID: 24224555 Review.

9

Polyamines and neoplastic growth.

Pegg AE, Feith DJ. Pegg AE, et al. Biochem Soc Trans. 2007 Apr;35(Pt 2):295-9. doi: 10.1042/BST0350295. Biochem Soc Trans. 2007. PMID: 17371264

10

S-adenosylmethionine decarboxylase as an enzyme target for therapy.

Pegg AE, McCann PP. Pegg AE, et al. Pharmacol Ther. 1992 Dec;56(3):359-77. doi: 10.1016/0163-7258(92)90025-u. Pharmacol Ther. 1992. PMID: 1301596 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

562 results

Search Page